Looking for SARS-coV-2 therapeutics through computational approaches

M Vincenzi, FA Mercurio… - Current Medicinal …, 2023 - ingentaconnect.com
Background: In the last few years, in silico tools, including drug repurposing coupled with
structure-based virtual screening, have been extensively employed to look for anti-COVID …

Structure based drug designing approaches in SARS-CoV-2 spike inhibitor design

A Shanmugam, A Venkattappan… - Current Topics in …, 2022 - ingentaconnect.com
The COVID-19 outbreak and the pandemic situation have hastened the research community
to design a novel drug and vaccine against its causative organism, the SARS-CoV-2. The …

A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression

P Wang, F Yan, J Dong, S Wang, Y Shi… - Physical Chemistry …, 2023 - pubs.rsc.org
Depression severely impairs the health of people all over the world. Cognitive dysfunction
due to depression has resulted in a severe economic burden to family and society induced …

Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2

JX Lima Neto, KS Bezerra, ED Barbosa… - Frontiers in molecular …, 2024 - frontiersin.org
Background: The RNA-dependent RNA polymerase (RdRp) complex, essential in viral
transcription and replication, is a key target for antiviral therapeutics. The core unit of RdRp …

Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and …

G Gupta, G Verkhivker - International Journal of Molecular Sciences, 2024 - mdpi.com
Understanding mechanisms of allosteric regulation remains elusive for the SARS-CoV-2
spike protein, despite the increasing interest and effort in discovering allosteric inhibitors of …

The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2

K Otazu, GE Olivos-Ramirez… - Journal of Molecular …, 2024 - Springer
Abstract Context SARS-CoV-2, responsible for COVID-19, has led to over 500 million
infections and more than 6 million deaths globally. There have been limited effective …

In silico validation of allosteric inhibitors targeting Zika virus NS2B–NS3 protease

YT Wang, YC Hsieh, TY Wu - Physical Chemistry Chemical Physics, 2024 - pubs.rsc.org
The Zika virus (ZIKV), a member of the Flaviviridae family, poses a major threat to human
health because of the lack of effective antiviral drugs. Although the NS2B–NS3 protease of …

Docking and other computing tools in drug design against SARS-CoV-2

AV Sulimov, IS Ilin, AS Tashchilova… - SAR and QSAR in …, 2024 - Taylor & Francis
The use of computer simulation methods has become an indispensable component in
identifying drugs against the SARS-CoV-2 coronavirus. There is a huge body of literature on …

In Silico Protein Structure Analysis for SARS-CoV-2 Vaccines Using Deep Learning

Y Matsuzaka, R Yashiro - BioMedInformatics, 2023 - mdpi.com
Protein three-dimensional structural analysis using artificial intelligence is attracting
attention in various fields, such as the estimation of vaccine structure and stability. In …

Computational Molecular Docking Studies of Small Molecule Inhibitors With the SARS-CoV-2 Spike Protein Variants: In-Silico Drug Discovery Using Virtual Screening …

G Gupta - 2023 - search.proquest.com
The pandemic caused by the emergence of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) in 2019 has caused a global public health crisis of nearly …